Peter S Garcia - Net Worth and Insider Trading

Peter S Garcia Net Worth

The estimated net worth of Peter S Garcia is at least $1 Million dollars as of 2024-10-06. Peter S Garcia is the Vice President, CFO of PDL BioPharma Inc and owns about 472,842 shares of PDL BioPharma Inc (PDLI) stock worth over $1 Million. Peter S Garcia is the CHIEF FINANCIAL OFFICER of ALX Oncology Holdings Inc and owns about 122,348 shares of ALX Oncology Holdings Inc (ALXO) stock worth over $204,321. Peter S Garcia is also the CFO of Lineage Cell Therapeutics Inc and owns about 7,000 shares of Lineage Cell Therapeutics Inc (LCTX) stock worth over $6,370. Details can be seen in Peter S Garcia's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Peter S Garcia has not made any transactions after 2024-06-13 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Peter S Garcia

To

Peter S Garcia Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Peter S Garcia owns 6 companies in total, including ALX Oncology Holdings Inc (ALXO) , PDL BioPharma Inc (PDLI) , and Lineage Cell Therapeutics Inc (LCTX) among others .

Click here to see the complete history of Peter S Garcia’s form 4 insider trades.

Insider Ownership Summary of Peter S Garcia

Ticker Comapny Transaction Date Type of Owner
ALXO ALX Oncology Holdings Inc 2024-06-13 Chief Financial Officer
PDLI PDL BioPharma Inc 2019-03-28 Vice President & CFO
LCTX Lineage Cell Therapeutics Inc 2012-03-19 Chief Financial Officer
LIMIT LIMIT 2009-07-13 Chief Financial Officer
LIMIT LIMIT 2004-05-07 Senior V.P. and C.F.O.
LIMIT LIMIT 2021-12-13 director

Peter S Garcia Latest Holdings Summary

Peter S Garcia currently owns a total of 3 stocks. Among these stocks, Peter S Garcia owns 472,842 shares of PDL BioPharma Inc (PDLI) as of March 24, 2017, with a value of $1 Million and a weighting of 84.72%. Peter S Garcia owns 122,348 shares of ALX Oncology Holdings Inc (ALXO) as of June 13, 2024, with a value of $204,321 and a weighting of 14.82%. Peter S Garcia also owns 7,000 shares of Lineage Cell Therapeutics Inc (LCTX) as of March 19, 2012, with a value of $6,370 and a weighting of 0.46%.

Latest Holdings of Peter S Garcia

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
PDLI PDL BioPharma Inc 2017-03-24 472,842 2.47 1,167,920
ALXO ALX Oncology Holdings Inc 2024-06-13 122,348 1.67 204,321
LCTX Lineage Cell Therapeutics Inc 2012-03-19 7,000 0.91 6,370

Holding Weightings of Peter S Garcia


Peter S Garcia Form 4 Trading Tracker

According to the SEC Form 4 filings, Peter S Garcia has made a total of 0 transactions in PDL BioPharma Inc (PDLI) over the past 5 years. The most-recent trade in PDL BioPharma Inc is the acquisition of 25,000 shares on March 24, 2017, which cost Peter S Garcia around $49,500.

According to the SEC Form 4 filings, Peter S Garcia has made a total of 8 transactions in ALX Oncology Holdings Inc (ALXO) over the past 5 years, including 3 buys and 5 sells. The most-recent trade in ALX Oncology Holdings Inc is the acquisition of 12,000 shares on June 13, 2024, which cost Peter S Garcia around $102,360.

According to the SEC Form 4 filings, Peter S Garcia has made a total of 0 transactions in Lineage Cell Therapeutics Inc (LCTX) over the past 5 years. The most-recent trade in Lineage Cell Therapeutics Inc is the acquisition of 5,000 shares on March 19, 2012, which cost Peter S Garcia around $23,400.

Insider Trading History of Peter S Garcia

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Peter S Garcia Trading Performance

GuruFocus tracks the stock performance after each of Peter S Garcia's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Peter S Garcia is -12.09%. GuruFocus also compares Peter S Garcia's trading performance to market benchmark return within the same time period. The performance of stocks bought by Peter S Garcia within 3 months outperforms 4 times out of 9 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Peter S Garcia's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Peter S Garcia

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
2 out of 7 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 1.97 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 2.14 LIMIT LIMIT LIMIT LIMIT LIMIT

Peter S Garcia Ownership Network

Ownership Network List of Peter S Garcia

No Data

Ownership Network Relation of Peter S Garcia

Insider Network Chart

Peter S Garcia Owned Company Details

What does ALX Oncology Holdings Inc do?

Who are the key executives at ALX Oncology Holdings Inc?

Peter S Garcia is the Chief Financial Officer of ALX Oncology Holdings Inc. Other key executives at ALX Oncology Holdings Inc include VP & Finance and CAO Shelly Pinto , Chief Medical Officer Sophia Randolph , and director & President and CEO Jaume Pons .

ALX Oncology Holdings Inc (ALXO) Insider Trades Summary

Over the past 18 months, Peter S Garcia made 3 insider transaction in ALX Oncology Holdings Inc (ALXO) with a net purchase of 23,113. Other recent insider transactions involving ALX Oncology Holdings Inc (ALXO) include a net sale of 145,903 shares made by Jaume Pons , a net sale of 14,288 shares made by Shelly Pinto , and a net sale of 18,243 shares made by Sophia Randolph .

In summary, during the past 3 months, insiders sold 23,866 shares of ALX Oncology Holdings Inc (ALXO) in total and bought 0 shares, with a net sale of 23,866 shares. During the past 18 months, 179,321 shares of ALX Oncology Holdings Inc (ALXO) were sold and 28,400 shares were bought by its insiders, resulting in a net sale of 150,921 shares.

ALX Oncology Holdings Inc (ALXO)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

ALX Oncology Holdings Inc Insider Transactions

No Available Data

Peter S Garcia Mailing Address

Above is the net worth, insider trading, and ownership report for Peter S Garcia. You might contact Peter S Garcia via mailing address: Alx Oncology Holdings Inc., 866 Malcolm Road, Suite 100, Burlingame Ca 94010.

Discussions on Peter S Garcia

No discussions yet.